Research and Markets: Rubber Antioxidant BLE (CAS 68412-48-6) Market Research ... - SunHerald.com

Research and Markets: Rubber Antioxidant BLE (CAS 68412-48-6) Market Research ... SunHerald.com The study Rubber Antioxidant BLE (CAS 68412-48-6) Market Research Report 2012' presents an overview of the Rubber Antioxidant BLE market globally and regionally by contemplating and analyzing its parameters. The report is based on reliable data and ... and more »

New Studies Highlight Health Benefits of the Exceptional Cranberry - MarketWatch (press release)

New Studies Highlight Health Benefits of the Exceptional Cranberry MarketWatch (press release) Now, new research provides additional evidence of these benefits while also examining how the cranberry helps bolster immunity and antioxidant support. A summary of the abstracts are highlighted below. With 15 million urinary tract infection (UTI) ... and more »

Testing Antioxidant Power of Foods - Wall Street Journal

Testing Antioxidant Power of Foods Wall Street Journal ... nutrition at the USDA's Agricultural Research Service. "The values have nothing to do with whether a food is healthy for you or not." The problem with ORAC, says Dr. Ames of UC Berkeley, is that a substance that looks like an excellent antioxidant ...

Nutrient dense nutrition bar shows 'striking' metabolic benefits - NutraIngredients-usa.com

Nutrient dense nutrition bar shows 'striking' metabolic benefits NutraIngredients-usa.com A low-calorie, high-fiber, nutrient-dense supplement bar may boost the feeling of fullness, and improve a number of health markers like HDL cholesterol and antioxidant defenses, says a new study. The “CHORI-bar” – named after the Children's Hospital ...

Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering ... - MarketWatch (press release)

Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering ... MarketWatch (press release) "Intellect Neurosciences is at the forefront of Alzheimer's research, with a rich pipeline and intellectual property portfolio and licensed products in late-stage clinical development," said Dr. Chain. "We embrace opportunities like this one and ... and more »